BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16185561)

  • 21. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
    Monsonego J; Pintos J; Semaille C; Beumont M; Dachez R; Zerat L; Bianchi A; Franco E
    Int J Gynecol Cancer; 2006; 16(2):591-8. PubMed ID: 16681731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effectiveness of cytodiagnostics, molecular identification of HPV HR and CINtecPLUS test to identify LG SIL and HG SIL.
    Rokita W; Kedzia W; Pruski D; Friebe Z; Nowak-Markwitz E; Spaczyński R; Karowicz-Bilińska A; Spaczyński M
    Ginekol Pol; 2012 Dec; 83(12):894-8. PubMed ID: 23488290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of high risk human papillomavirus cervical infections by the hybrid capture in Asunción, Paraguay.
    Torres LM; Páez M; Insaurralde A; Rodriguez MI; Castro A; Kasamatsu E
    Braz J Infect Dis; 2009 Jun; 13(3):203-6. PubMed ID: 20191197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
    Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.
    Arora R; Kumar A; Prusty BK; Kailash U; Batra S; Das BC
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):104-9. PubMed ID: 15950365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-risk human papillomavirus deoxyribonucleic acid as an adjunct marker in cervical cytology.
    Lin CT; Tseng CJ; Chou HH; Huang KG; Chang TC; Lai HH; Soong YK
    Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):409-15. PubMed ID: 10584412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.
    Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Woodward L
    J Fam Pract; 1998 Feb; 46(2):136-41. PubMed ID: 9487319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus load in Hybrid Capture II assay: does increasing the cutoff improve the test?
    Ordi J; Alonso I; Torné A; Esteve R; Sierra E; Campo E; Puig-Tintoré LM
    Gynecol Oncol; 2005 Nov; 99(2):313-9. PubMed ID: 16112180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities.
    Andersson S; Dillner L; Elfgren K; Mints M; Persson M; Rylander E
    Acta Obstet Gynecol Scand; 2005 Oct; 84(10):996-1000. PubMed ID: 16167918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.
    Ivanov MK; Titov SE; Glushkov SA; Dzyubenko VV; Malek AV; Arkhangelskaya PA; Samsonov RB; Mikhetko AA; Bakhidze EV; Berlev IV; Kolesnikov NN
    Oncol Rep; 2018 Mar; 39(3):1099-1111. PubMed ID: 29328473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection and genotyping of high-risk human papillomavirus in cervical specimens].
    Chacón J; Sanz I; Rubio MD; de la Morena ML; Díaz E; Mateos ML; Baquero F
    Enferm Infecc Microbiol Clin; 2007 May; 25(5):311-6. PubMed ID: 17504684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction.
    Riethmuller D; Gay C; Bertrand X; Bettinger D; Schaal JP; Carbillet JP; Lassabe C; Arveux P; Seilles E; Mougin C
    Diagn Mol Pathol; 1999 Sep; 8(3):157-64. PubMed ID: 10565688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of atypical squamous cells of undetermined significance on ThinPrep papanicolaou smears.
    Eltabbakh GH; Lipman JN; Mount SL; Morgan A
    Gynecol Oncol; 2000 Oct; 79(1):44-9. PubMed ID: 11006029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.
    Monsonego J; Bohbot JM; Pollini G; Krawec C; Vincent C; Merignargues I; Haroun F; Sednaoui P; Monfort L; Dachez R; Syrjänen K
    Gynecol Oncol; 2005 Oct; 99(1):160-8. PubMed ID: 16023184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of the in situ detection of HPV in Pap smears diagnosed as within normal limits.
    Menezes G; Euscher E; Schwartz B; Catania F; Chancellor J; Nuovo GJ
    Acta Cytol; 2001; 45(6):919-26. PubMed ID: 11726118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion.
    Wu HH; Allen SL; Kirkpatrick JL; Elsheikh TM
    Diagn Cytopathol; 2006 Oct; 34(10):707-10. PubMed ID: 16955480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.